EARLY DIFFERENTIATION BETWEEN SEPSIS AND STERILE INFLAMMATION VIA URINARY GENE SIGNATURES OF METABOLIC DYSREGULATION

ABSTRACT Objective: The aim of this study was to characterize early urinary gene expression differences between patients with sepsis and patients with sterile inflammation and summarize in terms of a reproducible sepsis probability score. Design: This was a prospective observational cohort study. Setting: The study was conducted in a quaternary care academic hospital. Patients: One hundred eighty-six sepsis patients and 78 systemic inflammatory response syndrome (SIRS) patients enrolled between January 2015 and February 2018. Interventions: Whole-genome transcriptomic analysis of RNA was extracted from urine obtained from sepsis patients within 12 hours of sepsis onset and from patients with surgery-acquired SIRS within 4 hours after major inpatient surgery. Measurements and Main Results: We identified 422 of 23,956 genes (1.7%) that were differentially expressed between sepsis and SIRS patients. Differentially expressed probes were provided to a collection of machine learning feature selection models to identify focused probe sets that differentiate between sepsis and SIRS. These probe sets were combined to find an optimal probe set (UrSepsisModel) and calculate a urinary sepsis score (UrSepsisScore), which is the geometric mean of downregulated genes subtracted from the geometric mean of upregulated genes. This approach summarizes the expression values of all decisive genes as a single sepsis score. The UrSepsisModel and UrSepsisScore achieved area under the receiver operating characteristic curves 0.91 (95% confidence interval, 0.86–0.96) and 0.80 (95% confidence interval, 0.70–0.88) on the validation cohort, respectively. Functional analyses of probes associated with sepsis demonstrated metabolic dysregulation manifest as reduced oxidative phosphorylation, decreased amino acid metabolism, and decreased oxidation of lipids and fatty acids. Conclusions: Whole-genome transcriptomic profiling of urinary cells revealed focused probe panels that can function as an early diagnostic tool for differentiating sepsis from sterile SIRS. Functional analysis of differentially expressed genes demonstrated a distinct metabolic dysregulation signature in sepsis.

[1]  H. Baker,et al.  Discovery and Validation of Urinary Molecular Signature of Early Sepsis , 2020, Critical care explorations.

[2]  Ó. Peñuelas,et al.  Histopathological changes of organ dysfunction in sepsis , 2019, Intensive Care Medicine Experimental.

[3]  M. Kollef,et al.  Rationalizing antimicrobial therapy in the ICU: a narrative review , 2019, Intensive Care Medicine.

[4]  B. Brumback,et al.  Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients , 2017, BMJ Open.

[5]  G. Kovacs,et al.  Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance , 2017, Clinical chemistry and laboratory medicine.

[6]  L. Joosten,et al.  Cellular metabolism of myeloid cells in sepsis , 2017, Journal of leukocyte biology.

[7]  J. Vincent,et al.  The Clinical Challenge of Sepsis Identification and Monitoring , 2016, PLoS medicine.

[8]  D. Lobo,et al.  Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome , 2015, Critical Care.

[9]  Xuan Li,et al.  Dynamic Changes in Amino Acid Concentration Profiles in Patients with Sepsis , 2015, PloS one.

[10]  A. Gabrielli,et al.  Computer versus paper system for recognition and management of sepsis in surgical intensive care , 2014, The journal of trauma and acute care surgery.

[11]  Stephanie J. Reisinger,et al.  An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis , 2013, Science Translational Medicine.

[12]  H. Wong,et al.  Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children , 2012, Critical Care.

[13]  L. Su,et al.  Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study , 2012, BMC Nephrology.

[14]  H. Wong,et al.  Reduced Peroxisome Proliferator-Activated Receptor &agr; Expression Is Associated With Decreased Survival and Increased Tissue Bacterial Load in Sepsis , 2012, Shock.

[15]  L. Su,et al.  Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study , 2011, Critical care.

[16]  Benjamin Tang,et al.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.

[17]  Michael Müller,et al.  Peroxisome Proliferator-Activated Receptor Alpha Target Genes , 2010, PPAR research.

[18]  Witold R. Rudnicki,et al.  Feature Selection with the Boruta Package , 2010 .

[19]  M. Harboe,et al.  Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis , 2009, Scandinavian journal of immunology.

[20]  Thomas P. Shanley,et al.  Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum* , 2009, Critical care medicine.

[21]  S. Lowry,et al.  The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation. , 2009, The Surgical clinics of North America.

[22]  Ian W. Dawes,et al.  Gene-expression profiling of peripheral blood mononuclear cells in sepsis* , 2009, Critical care medicine.

[23]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Bulletin of the World Health Organization.

[24]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[25]  Steven B. Johnson,et al.  Gene Expression Profiles Differentiate Between Sterile SIRS and Early Sepsis , 2007, Annals of surgery.

[26]  J. Gardner-Thorpe,et al.  The value of Modified Early Warning Score (MEWS) in surgical in-patients: a prospective observational study. , 2006, Annals of the Royal College of Surgeons of England.

[27]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[28]  Alexander R. Abbas,et al.  Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data , 2005, Genes and Immunity.

[29]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[30]  Jean-Christophe Aude,et al.  A panoramic view of gene expression in the human kidney , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[32]  P. Chomczyński,et al.  A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. , 1993, BioTechniques.

[33]  R. Bone,et al.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.

[34]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[35]  Purvesh Khatri,et al.  Benchmarking Sepsis Gene Expression Diagnostics Using Public Data* , 2017, Critical care medicine.

[36]  L. Moldawer,et al.  DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis. , 2013, Shock.